Email Newsletters

Marlborough

Movers & Shakers for April 15, 2024

People are moving up at Cornerstone Bank, the Marlborough Economic Development Council, and bankHometown.

🔒Gov. Healey’s proposed $1B life sciences reauthorization has Central Mass. leaders thinking big

For the burgeoning life sciences hub that is Central Massachusetts, Governor Maura Healey’s $3.5-billion Mass Leads Act economic development proposal looks to add fuel to fires.

Marlborough chamber selects Michelle Mercier as next CEO

“Michelle offers a unique talent for leadership that will enhance the organization beyond measure,” Tye Jordan, chair of the chamber’s board of directors and regional director of Worcester-based Cinch I.T, said in the press release.

Movers & Shakers for April 1, 2024

Central Massachusetts professionals are getting hired and promoted at Workers Credit Union, Spectrum Health Systems, Fidelity Bank, and Fallon Health
ADVERTISEMENT

Marlborough launches new interactive property tool for businesses

The Marlborough Economic Development Corp. has developed a new interactive tool, MapLink, to allow businesses and developers looking to invest in the city easy access to pertinent zoning information.

Boston Scientific raises $2.2B to support purchase of California medical device company

The primary use of the funds will be used to fund Boston Scientific’s purchase of Axonics, Inc., a $3.7-billion transaction the company announced in January. 

Marlborough luxury apartment complex sold for $95M to New York firm

A luxury apartment complex situated near Route 495 in Marlborough has been sold for $95 million.
ADVERTISEMENT

Biomedical firm with Marlborough location hires new CEO

Bruning, who has served on StageBio’s board of directors for the previous five years, has more than 25 years of experience with companies providing preclinical testing services.

Boston Scientific receives FDA approval for opioid-alternate back pain treatment

Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low back and leg pain deriving from a condition referred to as non-surgical back pain. 
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA